home All News open_in_new Full Article
Dogwood Therapeutics, Inc. Announces Conversion of Existing $19.5M in Debt to Equity, Strengthening Balance Sheet Moving Forward
Dogwood Therapeutics (Nasdaq: DWTX) announced that CK Life Sciences Int'l., (Holdings) Inc., its largest shareholder, agreed to convert $19.5 million in debt to equity in exchange for preferred equity, removing all existing debt from Dogwood's balance sheet. This is expected to strengthen Dogwood's balance sheet and make it a more attractive investment opportunity. The conversion ensures sufficient capital for the Halneuron Phase 2b chemotherapy-induced neuropathic pain trial.
today 48 h. ago attach_file Economics
attach_file
Other
attach_file
Economics
attach_file
Economics
attach_file
Other
attach_file
Economics
attach_file
Economics
attach_file
Economics
ID: 81684614